VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL APPLICATION SUBMISSION OF NOVEL DUAL TARGETING SIRNA SR122 FOR TREATMENT OF MIXED DYSLIPIDEMIA AND SEVERE HYPERTRIGLYCERIDEMIA
06938 Suzhou Ribo Life Science Co., Ltd.RIBOLIFE-BHong Kong Stock Exchange
4 posts
Suzhou Ribo Life Science Co., Ltd. (06938) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Suzhou Ribo Life Science Co., Ltd. (06938) Stock Price History
Suzhou Ribo Life Science Co., Ltd. closed at HK$45.52 on Nov 11, 2026, −18.6% over 1 month.
If you had invested HK$10,000 1 month ago, it would be worth HK$8,345 today (−16.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +0.2%, while this stock moved −16.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$45.52 | +0.98 | +2.20% |
| Nov 10 (Tue) | HK$44.54 | +1.16 | +2.67% |
| Nov 9 (Mon) | HK$43.38 | +0.20 | +0.46% |
| Nov 6 (Fri) | HK$43.18 | −1.12 | −2.53% |
| Nov 5 (Thu) | HK$44.30 | +0.90 | +2.07% |
| Nov 4 (Wed) | HK$43.40 | +1.90 | +4.58% |
| Nov 3 (Tue) | HK$41.50 | −0.36 | −0.86% |
| Nov 2 (Mon) | HK$41.86 | +0.02 | +0.05% |
| Oct 30 (Fri) | HK$41.84 | −1.16 | −2.70% |
| Oct 29 (Thu) | HK$43.00 | −1.08 | −2.45% |
If you had invested HK$10,000 3 months ago, it would be worth HK$8,540 today (−14.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.2%, while this stock moved −14.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$45.52 | +0.98 | +2.20% |
| Nov 10 (Tue) | HK$44.54 | +1.16 | +2.67% |
| Nov 9 (Mon) | HK$43.38 | +0.20 | +0.46% |
| Nov 6 (Fri) | HK$43.18 | −1.12 | −2.53% |
| Nov 5 (Thu) | HK$44.30 | +0.90 | +2.07% |
| Nov 4 (Wed) | HK$43.40 | +1.90 | +4.58% |
| Nov 3 (Tue) | HK$41.50 | −0.36 | −0.86% |
| Nov 2 (Mon) | HK$41.86 | +0.02 | +0.05% |
| Oct 30 (Fri) | HK$41.84 | −1.16 | −2.70% |
| Oct 29 (Thu) | HK$43.00 | −1.08 | −2.45% |
If you had invested HK$10,000 6 months ago, it would be worth HK$7,462 today (−25.4%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved −25.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$45.52 | +8.8% |
| Oct 2026 | HK$41.84 | −26.5% |
| Sep 2026 | HK$56.95 | −5.5% |
| Aug 2026 | HK$60.25 | +27.8% |
| Jul 2026 | HK$47.16 | +0.6% |
| Jun 2026 | HK$46.90 | −19.4% |
| May 2026 | HK$58.20 | −4.4% |
If you had invested HK$10,000 1 year ago, it would be worth HK$5,544 today (−44.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.3%, while this stock moved −44.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$45.52 | +8.8% |
| Oct 2026 | HK$41.84 | −26.5% |
| Sep 2026 | HK$56.95 | −5.5% |
| Aug 2026 | HK$60.25 | +27.8% |
| Jul 2026 | HK$47.16 | +0.6% |
| Jun 2026 | HK$46.90 | −19.4% |
| May 2026 | HK$58.20 | −4.4% |
| Apr 2026 | HK$60.90 | +6.3% |
| Mar 2026 | HK$57.30 | −16.4% |
| Feb 2026 | HK$68.50 | −0.4% |
| Jan 2026 | HK$68.80 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2026). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL APPLICATION SUBMISSION OF NOVEL DUAL TARGETING SIRNA SR122 FOR TREATMENT OF MIXED DYSLIPIDEMIA AND SEVERE HYPERTRIGLYCERIDEMIA
DISCLOSEABLE AND CONNECTED TRANSACTION ACQUISITION OF THE REMAINING 49.71% SHAREHOLDING IN A SUBSIDIARY INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; AND PROPOSED CHANGE OF REGISTERED CAPITAL AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Delete
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL APPLICATION SUBMISSION OF RBD3133 INJECTION FOR OVERWEIGHT AND OBESITY
Delete
2026 INTERIM REPORT
Delete
Write on the Suzhou Ribo Life Science Co., Ltd. board
More Chinese stocks in English
- MEGAIN Holding (Cayman) Co., Ltd.06939
- CHAOZHOU THREE-CIRCLE (GROUP) CO.,LTD.06951
- Shandong Boan Biotechnology Co., Ltd.06955
- ZHENRO SERVICES GROUP LIMITED06958
- Changjiu Holdings Limited06959
- SHUANGDENG GROUP CO.,LTD.06960
- Sunshine Insurance Group Company Limited06963
- China Wan Tong Yuan (Holdings) Limited06966
- Ganglong China Property Group Limited06968
- Smoore International Holdings Limited06969
- Immunotech Biopharm Ltd06978
- ZJLD Group Inc06979